Announcements Trials

Browse Landscape

Phase

Phase 2 5 Phase 1 2 Phase NA 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 212 Cyclophosphamide 120 Nivolumab 110 Carboplatin 92 fludarabine 79 Gemcitabine 79 Specimen Handling 74 Bevacizumab 73 venetoclax 70 Injections 70 Magnetic Resonance Spectroscopy 68 Paclitaxel 66 Dexamethasone 66 Biopsy 59 atezolizumab 56 Cisplatin 54 Ipilimumab 49 Temozolomide 45 Lenalidomide 43 Docetaxel 43 Azacitidine 43 Pemetrexed 42 Rituximab 41 Oxaliplatin 40 Fluorouracil 40 Radiotherapy 39 Cetuximab 39 durvalumab 37 Cytarabine 36 Capecitabine 35

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Valacyclovir × 1 year × Clear all

NCT07346144 2026-05-04

ADePT

Trogenix ltd

Phase 1/2 Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡